Altis Biosystems Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $2.13M

  • Investors
  • 22

Altis Biosystems General Information

Description

Developer of a stem cell technology designed to recreate the human intestinal epithelium and colonic epithelium for compound screening and microbiome research. The company's technology produces a layer of human or animal intestinal stem and differentiated cells either of the small or large intestines, enabling scientists to develop safe and more effective drugs using normal human intestinal tissue and reducing the need for animal testing.

Contact Information

Website
www.altisbiosystems.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6 Davis Drive
  • Suite 159
  • Durham, NC 27709
  • United States
+1 (919)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 6 Davis Drive
  • Suite 159
  • Durham, NC 27709
  • United States
+1 (919)

Altis Biosystems Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Altis Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC (Series A2) 07-Apr-2025 $2.13M Completed Generating Revenue
14. Grant 01-Sep-2023 Completed Generating Revenue
13. Grant 01-Jul-2023 Completed Generating Revenue
12. Grant 30-Sep-2022 Completed Generating Revenue
11. Later Stage VC (Series A) 22-Sep-2022 Completed Generating Revenue
10. Grant 01-Jul-2022 Completed Generating Revenue
9. Debt - General 23-Jun-2022 Completed Generating Revenue
8. Grant 09-May-2022 Completed Generating Revenue
7. Grant 01-May-2022 $992K $3.15M Completed Generating Revenue
6. Grant 02-Feb-2021 $75K $3.15M Completed Generating Revenue
To view Altis Biosystems’s complete valuation and funding history, request access »

Altis Biosystems Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2
Series A
Seed-2 30,915 $0.001000 $2.23 $2.23 1x $2.23 0.75%
Seed-1 710,592 $0.001000 $4.27 $4.27 1x $4.27 17.23%
To view Altis Biosystems’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Altis Biosystems Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Altis Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026198515-A1 Cell co-culture systems and methods of use Pending 18-Mar-2025
WO-2026090172-A1 Cell culture systems comprising micropatterned arrays and methods of use Pending 21-Oct-2024

Altis Biosystems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Altis Biosystems Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
2ndF Family Office Minority
NC Tweener Fund Venture Capital Minority
Alexandria Venture Investments Venture Capital Minority
Bioventure Partners Venture Capital Minority
Checkmate Capital Venture Capital Minority
You’re viewing 5 of 22 investors. Get the full list »

Altis Biosystems Investments (1)

Altis Biosystems’s most recent deal was a Grant with Plakous Therapeutics for . The deal was made on 30-Dec-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Plakous Therapeutics 30-Dec-2022 Grant Drug Discovery
To view Altis Biosystems’s complete investments history, request access »

Ready to get started?

Request a free trial

Altis Biosystems FAQs

  • When was Altis Biosystems founded?

    Altis Biosystems was founded in 2015.

  • Where is Altis Biosystems headquartered?

    Altis Biosystems is headquartered in Durham, NC.

  • What is the size of Altis Biosystems?

    Altis Biosystems has 27 total employees.

  • What industry is Altis Biosystems in?

    Altis Biosystems’s primary industry is Biotechnology.

  • Is Altis Biosystems a private or public company?

    Altis Biosystems is a Private company.

  • What is the current valuation of Altis Biosystems?

    The current valuation of Altis Biosystems is .

  • What is Altis Biosystems’s current revenue?

    The current revenue for Altis Biosystems is .

  • How much funding has Altis Biosystems raised over time?

    Altis Biosystems has raised $8.78M.

  • Who are Altis Biosystems’s investors?

    2ndF, NC Tweener Fund, Alexandria Venture Investments, Bioventure Partners, and Checkmate Capital are 5 of 22 investors who have invested in Altis Biosystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process